Ownership history in GILEAD SCIENCES, INC. · 5 quarters on record
This page tracks every 13F SEC filing in which GILEAD SCIENCES, INC. reported a position in KYVERNA THERAPEUTICS INC (KYTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 4,126,119 | — | 0% | 2.00% | $38.8M | $9.40 |
| 2025 Q3 | UNCHANGED | 4,126,119 | — | 0% | 1.38% | $24.8M | $6.00 |
| 2025 Q2 | UNCHANGED | 4,126,119 | — | 0% | 0.99% | $12.67B | $3.07 |
| 2025 Q1 | UNCHANGED | 4,126,119 | — | 0% | 0.67% | $7.96B | $1.93 |
| 2024 Q4 | INITIATED | 4,126,119 | — | — | 0.99% | $15.43B | $3.74 |
As of 2025 Q4 — sorted by position size